A systematic review of the safety and efficacy of monoclonal antibodies for progressive multiple sclerosis

Z Sabahi, AD Sorkhabi, A Sarkesh, A Naseri… - International …, 2023 - Elsevier
Background Progressive multiple sclerosis (PMS) is a debilitating condition characterized by
progressively worsening symptoms. Monoclonal antibodies are novel therapies for MS, but …
被引用次数：4 相关文章

A systematic review of the safety and efficacy of monoclonal antibodies for progressive multiple sclerosis.

Z Sabahi, A Sarkesh, A Naseri… - International …, 2023 - europepmc.org
Background Progressive multiple sclerosis (PMS) is a debilitating condition characterized by
progressively worsening symptoms. Monoclonal antibodies are novel therapies for MS, but …

A systematic review of the safety and efficacy of monoclonal antibodies for progressive multiple sclerosis

Z Sabahi, AD Sorkhabi, A Sarkesh… - International …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Progressive multiple sclerosis (PMS) is a debilitating condition characterized by
progressively worsening symptoms. Monoclonal antibodies are novel therapies for MS, but …